Griffonia (Griffonia simplicifolia)
What Is Griffonia?
Griffonia is catalogued in the Materia Medica under the binomial Griffonia simplicifolia, a plant of the Fabaceae family, native to the coastal forests of West Africa. The material in circulation is seed — the fruiting body of the plant. Most people search for it simply as Griffonia; suppliers, pharmacopoeias and interaction databases list it as Griffonia simplicifolia, and matching the two is the first step in identifying what is actually in a product. In the hand it reads as neutral, faintly beany — a practical marker of freshness and correct identification.
The written history of Griffonia begins with household and practitioner use — recipes, harvesting notes and cautions passed between regions — and only much later with laboratory description of what the seed contains. Beyond its practical use it carries cultural associations — West African vine of calm and rest.
Today most searches for Griffonia come from people reading about wound healing, appetite, sleep and headache, or checking how it sits alongside a medication they already take. The use most often documented in the literature is seed is the commercial source of 5-hydroxytryptophan, followed by studied for low mood, appetite regulation and sleep onset.
How Does Griffonia Work?
Griffonia works as a mixture rather than a single isolated compound, and its profile is usually described by the class of constituents present in seed rather than by one marker molecule.
The older understanding of Griffonia is procedural rather than molecular — which part to take, in what season, and in what medium — and modern constituent work has largely been an attempt to explain why those procedures were chosen.
The research base is developing: there are human trials, though sample sizes and designs vary, and this profile cites 1 source. Reported findings centre on seeds contain 6–14% 5-HTP by weight, which crosses the blood-brain barrier without transport competition and is decarboxylated to serotonin. Where research exists, it examines seed is the commercial source of 5-hydroxytryptophan, studied for low mood, appetite regulation and sleep onset and investigated in chronic headache prophylaxis. These are areas of study, not established outcomes, and results differ by preparation and dose.
How the plant is prepared changes what you actually get. Its constituents move readily into water and alcohol — so a preparation made in another medium will not carry the same fraction of the plant, which is why traditional recipes specify one over another.
What makes Griffonia distinct is the combination rather than any one molecule: the same compound classes appear in other botanicals, but their ratio here — and the seed they are drawn from — is what the traditional and research literature both describe.
Because these constituents are processed by the same pathways that handle many medicines, Griffonia is documented as interacting with ssris / snris, mao inhibitors and triptans. That is a question of shared metabolism rather than of potency, and it is the main reason the plant is listed in interaction references at all.
Dose, plant part and growing conditions all shift the constituent profile, so two products carrying the name Griffonia can differ substantially; this is why reference entries specify seed and, where they exist, standardisation markers.